Treatment and prognostic variables of Osteosarcoma cohort
Variable | Total (n=13) | Patients with event (n=6) | Patients without event (n=7) | |
---|---|---|---|---|
Metastatic disease | 4 (30.8%) | 3 (50.0%) | 1 (14.3%) | 0.2657 |
Lung mets | 4 (30.8%) | 3 (50%) | 1 (14.3%) | |
Chemotherapy | 13 (100%) | 6 (100%) | 7 (100.0%) | 0.1923 |
Limb salvage surgery | 8 (61.5%) | 3 (50.0%) | 5 (71.4%) | 0.7552 |
Negative microscopic margins | 11 (84.6%) | 6 (100.0%) | 5 (71.4%) | 0.4615 |
Tumor necrosis >90% | 3 (23.1%) | 0 | 3 (42.9%) | 0.1923 |
Functional disability at follow-up | 4 (30.8%) | 0 | 4 (57.1%) | 0.0699 |
Death | 4 (30.8%) | 4 (66.6%) | 0 | 0.0210 |
Disease progression as cause of death | 4 (30.8%) | 4 (66.6%) | 0 | 0.0210 |